Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
Apply
Olutasidenib & Azacitidine
Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step